Press Releases
Jul. 29, 2025
WHO cautions of increase of chikungunya disease
Indeterminate
MENAFN
Owner: Sawsan Dababneh
Mar. 18, 2026
Valneva Reports Full Year 2025 Audited Consolidated Financial Results
Indeterminate
GlobeNewswire, Inc.
May. 7, 2025
Valneva Provides Update Following European Medicines Agency Announcement on Use of IXCHIQ® in Elderly
Indeterminate
GlobeNewswire, Inc.
Mar. 3, 2026
Hypersanté Hosts First Francophone Summit on Longevity and Biohacking in Paris
Indeterminate
GlobeNewswire, Inc.
Apr. 26, 2025
Valneva Provides Update on Recommendation for Use of Its Chikungunya Vaccine by French Authorities
Indeterminate
GlobeNewswire, Inc.
Mar. 24, 2026
Pakistan Leads 2025 Global Pollution Rankings
Indeterminate
MENAFN
Owner: Sawsan Dababneh
Feb. 13, 2026
Valneva Provides Update on Recommendations for Use of IXCHIQ® in the United Kingdom
Indeterminate
GlobeNewswire, Inc.
Mar. 1, 2026
Grand Park Kodhipparu Launches ‘Island Celebrations: EID – Connect in Paradise’
Neutral
EIN Presswire
Dec. 11, 2025
Hypersante Introduces the 2026 Longevity and Biohacking Summit in Paris
Indeterminate
GlobeNewswire, Inc.
Nov. 20, 2025
Valneva Reports Nine-Month 2025 Financial Results and Provides Corporate Updates
Indeterminate
GlobeNewswire, Inc.
Feb. 10, 2026
TGR Foundation Celebrates 20 Years of Impact Through Education at TGR Learning Lab in Anaheim
Indeterminate
GlobeNewswire, Inc.
Aug. 12, 2025
Valneva Reports Half Year 2025 Financial Results and Provides Corporate Updates
Indeterminate
GlobeNewswire, Inc.
Jul. 28, 2025
WHO cautions against increase of chikungunya illness
Indeterminate
MENAFN
Owner: Sawsan Dababneh
Jul. 22, 2025
WHO Cautions Chikungunya Spread Threatens Billions
Indeterminate
MENAFN
Owner: Sawsan Dababneh
Aug. 25, 2025
Valneva Announces FDA’s Decision to Suspend License of Chikungunya Vaccine IXCHIQ® in the U.S.
Indeterminate
GlobeNewswire, Inc.
May. 12, 2025
Valneva Provides Update on Recommended Use of IXCHIQ® by Elderly Individuals in the United States
Indeterminate
GlobeNewswire, Inc.